News: RHY Rhythm Biosciences Files With TGA To List Colostat On Register Of Therapeutic Goods, page-37

Remember when I said there was a review of the National Bowel Cancer Screening Program? It was just released and closed for review June 17 2022

Here it is: https://consultations.health.gov.au/hearing-and-program-support-division/review-the-national-bowel-cancer-screening-program/supporting_documents/NBCSP%20Review%20Report.PDF

RHY and Sonic Healthcare were consulted (mind you back in 2020 we’ll before our TGA submission it’s in the endnotes). Here’s a snippet from the report, pg 34

“In any decision to transition to a new test type, it is important that the test is approved by the Therapeutic Goods Administration (as per the guidance in the NBCSP Quality Framework) and a cost-effectiveness analysis is performed using reliable estimates of test sensitivity and specificity, as compared with the current iFOBT.”